Lighthouse Investment Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
7,500
-25,132
-77% -$4.81M 0.04% 399
2026
Q1
$5.98M Buy
32,632
+26,844
+464% +$4.95M 0.21% 163
2025
Q4
$1.02M Sell
5,788
-22,212
-79% -$3.63M 0.03% 476
2025
Q3
$3.92M Buy
+28,000
New +$3.78M 0.12% 230
2024
Q3
– Sell
-23,713
Closed -$5.5M – 439
2024
Q2
$5.5M Buy
+23,713
New +$5.15M 0.22% 120
2024
Q1
– Sell
-1,053
Closed -$272K – 381
2023
Q4
$272K Buy
+1,053
New +$259K 0.01% 270

Other funds holding BIIB

Lighthouse Investment Partners's BIIB Position: Q2 2026 in Review

Lighthouse Investment Partners reduced its Biogen (BIIB) stake by 77% in Q2 2026, selling an estimated $4.81M and leaving 7,500 shares worth $1.62M. The position accounts for 0.04% of the portfolio, ranked #399.

Lighthouse Investment Partners first reported a position in BIIB in Q4 2023 and has held it in 6 quarters since. The position peaked at $5.98M in Q1 2026. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Lighthouse Investment Partners held 7,500 shares of Biogen worth $1.62M as of Q2 2026.
  • Lighthouse Investment Partners sold 25,132 Biogen shares in Q2 2026, an estimated $4.81M.
  • Biogen made up 0.04% of Lighthouse Investment Partners's portfolio in Q2 2026, its #399 holding.
  • Lighthouse Investment Partners first reported a position in Biogen in Q4 2023 and has held it in 6 quarters since.
  • Lighthouse Investment Partners's Biogen position peaked at $5.98M in Q1 2026.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.